U.S. Formulation Development Outsourcing Market · GlobeNewswire Inc. Dublin, Oct. 28, 2025 (GLOBE NEWSWIRE) -- The "United States Formulation Development Outsourcing Market Report by Service, ...

Formulation Development Outsourcing Market · GlobeNewswire Inc. Dublin, July 30, 2025 (GLOBE NEWSWIRE) -- The "Pharma Formulation Development Outsourcing Market Size and Growth Trends and Companies ...

Overcoming common challenges with today’s biologics, such as developing devices for high-concentration subcutaneous ...

The global formulation development outsourcing market is on a significant growth trajectory, with a projected compound annual growth rate (CAGR) of 7.2% over the next decade. Valued at USD 33.23 ...

A biotech company based in Spain says that new formulations are allowing the organization to deliver larger molecules straight to the pulmonary system. RidNova Pharmaceuticals says it’s using ...

eTheRNA Manufacturing, a specialist CDMO member of the Belgian eTheRNA group, is introducing a new Lipid Nanoparticle (LNP) formulation development and production service to support the discovery and ...

The global formulation development outsourcing industry was estimated at $22.5 billion in 2021, and is anticipated to hit $51.9 billion by 2031, registering a CAGR of 9% from 2022 to 2031. The ...

Christine Allen, CEO and Co-Founder of Intrepid Labs, and Andy Lewis, CSO at Quotient Sciences, highlight their strategic ...

Suzanne Jansen, MSc, PharmD, ICON, says early-phase clinical success depends on flexible, simple formulations that support wide dose ranges, matching placebos, and robust stability. Formulations are ...

A new generation of interactive formulation development platforms can leave trial and error in the formulation process in the past. Development of any new drug ...

Inhibitor Therapeutics, Inc. (OTCQB: INTI) ("Inhibitor" or the "Company"), today provided an update on its ongoing pharmacokinetic (PK) clinical program supporting the treatment of surgically eligible ...